Recurrent Gray-Zone Lymphoma

Explore clinical trials studying Recurrent Gray-Zone Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Gray-Zone Lymphoma trial results

Completed

NCT02568553

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

View all 24 locations

Active, Not Recruiting

NCT03038672

Conditions: ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +53 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Moffitt Cancer Center-International Plaza Tampa, Florida, United States

View all 33 locations